Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Sight Sciences Inc (SGHT)

Sight Sciences Inc (SGHT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 261,640
  • Shares Outstanding, K 49,553
  • Annual Sales, $ 81,060 K
  • Annual Income, $ -55,550 K
  • 60-Month Beta 2.83
  • Price/Sales 3.14
  • Price/Cash Flow N/A
  • Price/Book 2.08
Trade SGHT with:

Options Overview Details

View History
  • Implied Volatility 149.17% ( +42.94%)
  • Historical Volatility 72.49%
  • IV Percentile 89%
  • IV Rank 32.88%
  • IV High 371.93% on 11/08/23
  • IV Low 40.05% on 05/19/23
  • Put/Call Vol Ratio 0.01
  • Today's Volume 165
  • Volume Avg (30-Day) 39
  • Put/Call OI Ratio 0.92
  • Today's Open Interest 1,139
  • Open Int (30-Day) 1,023

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/24
See More
  • Average Estimate -0.29
  • Number of Estimates 4
  • High Estimate -0.21
  • Low Estimate -0.35
  • Prior Year -0.35
  • Growth Rate Est. (year over year) +17.14%

Price Performance

See More
Period Period Low Period High Performance
1-Month
4.88 +19.26%
on 04/03/24
6.34 -8.24%
on 04/11/24
+0.54 (+10.23%)
since 03/28/24
3-Month
4.01 +45.14%
on 03/01/24
6.34 -8.24%
on 04/11/24
+1.11 (+23.57%)
since 01/29/24
52-Week
1.04 +459.62%
on 10/27/23
11.20 -48.04%
on 05/01/23
-3.85 (-39.81%)
since 04/28/23

Most Recent Stories

More News
Stock Index Futures Slip as Investors Brace for U.S. Inflation Data, Oracle Results Disappoint

September S&P 500 futures (ESU23) are down -0.23%, and September Nasdaq 100 E-Mini futures (NQU23) are down -0.26% this morning as market participants exercised caution and refrained from taking big positions...

ESU23 : 4,491.72s (-0.32%)
NQU23 : 15,435.20s (-0.28%)
TSLA : 194.05 (+15.31%)
QCOM : 169.20 (+2.14%)
TWNK : 33.30 (-0.15%)
RTX : 102.44 (+1.02%)
ORCL : 116.49 (-0.61%)
ABF.LN : 2,654.000 (-0.08%)
SGHT : 5.82 (+10.23%)
SLRN : 4.24 (unch)
GERN : 4.14 (+9.23%)
AER : 86.74 (+1.46%)
How Much Upside is Left in Sight Sciences, Inc. (SGHT)? Wall Street Analysts Think 38.78%

The average of price targets set by Wall Street analysts indicates a potential upside of 38.8% in Sight Sciences, Inc. (SGHT). While the effectiveness of this highly sought-after metric is questionable,...

SGHT : 5.82 (+10.23%)
Sight Sciences, Inc. (SGHT) Reports Q1 Loss, Misses Revenue Estimates

Sight Sciences, Inc. (SGHT) delivered earnings and revenue surprises of 14.63% and 0.89%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

SGHT : 5.82 (+10.23%)
MASI : 136.20 (+0.04%)
Penumbra (PEN) Surpasses Q1 Earnings and Revenue Estimates

Penumbra (PEN) delivered earnings and revenue surprises of 109.09% and 4.69%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

PEN : 202.04 (-1.16%)
SGHT : 5.82 (+10.23%)
Strength Seen in Sight Sciences, Inc. (SGHT): Can Its 5.6% Jump Turn into More Strength?

Sight Sciences, Inc. (SGHT) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near...

SGHT : 5.82 (+10.23%)
AORT : 20.60 (+0.15%)
Sight Sciences, Inc. (SGHT) Reports Q4 Loss, Tops Revenue Estimates

Sight Sciences, Inc. (SGHT) delivered earnings and revenue surprises of 16.67% and 0.80%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

SGHT : 5.82 (+10.23%)
AWH : 3.33 (+0.10%)
908 Devices Inc. (MASS) Reports Q4 Loss, Tops Revenue Estimates

908 Devices Inc. (MASS) delivered earnings and revenue surprises of -40.91% and 1.77%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

MASS : 5.76 (+1.50%)
SGHT : 5.82 (+10.23%)
Stereotaxis Inc. (STXS) Reports Q4 Loss, Misses Revenue Estimates

Stereotaxis Inc. (STXS) delivered earnings and revenue surprises of 0% and 23.95%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

STXS : 2.30 (unch)
SGHT : 5.82 (+10.23%)
3 Prime Healthcare Takeover Targets

These three companies are attractive targets for their potential.

CRSP : 54.83 (+1.71%)
BMRN : 82.13 (+1.51%)
SGHT : 5.82 (+10.23%)
VRTX : 396.20 (-0.32%)
Sight Sciences, Inc. (SGHT) Reports Q3 Loss, Tops Revenue Estimates

Sight Sciences, Inc. (SGHT) delivered earnings and revenue surprises of 2.13% and 5.05%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

SGHT : 5.82 (+10.23%)
FBIO : 1.7200 (unch)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Strongest short term outlook on maintaining the current direction.

See More Share

Business Summary

Sight Sciences Inc. is a medical device company. It focused on the development and commercialization of proprietary devises which target the underlying causes of prevalent eye diseases. Sight Sciences Inc. is based in MENLO PARK, Calif.

See More

Key Turning Points

3rd Resistance Point 7.15
2nd Resistance Point 6.74
1st Resistance Point 6.28
Last Price 5.82
1st Support Level 5.41
2nd Support Level 5.00
3rd Support Level 4.54

See More

52-Week High 11.20
Fibonacci 61.8% 7.32
Fibonacci 50% 6.12
Last Price 5.82
Fibonacci 38.2% 4.92
52-Week Low 1.04

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar